Sheila Oren, MD MBA in

Sheila Oren, MD MBA

Login to view DISC.
Healthtech Community leader at Next October
📍 Herzliya, Tel Aviv District, Israel

Sheila Oren is a healthtech executive with over 25 years of experience leading drug and device development, particularly for neurological conditions. A co-founder and CEO, she has held senior roles at Teva, NeuroDerm, and Remepy, bringing a major Parkinsons drug from Phase 1 to market. She holds an MD from Tel Aviv University and an MBA from Reichman University.

Beyond her corporate roles, Sheila is a mentor and community leader dedicated to social impact through innovation. She leads the healthtech community for Next October, an initiative harnessing Israeli technology to honor victims of the October 2023 Hamas War. She is also an active member of the 8400 healthtech leadership network.

She played a pivotal role in NeuroDerms successful NASDAQ IPO and its subsequent acquisition by Mitsubishi Tanabe for $1. 1 billion.

Read the full overview →
Experience
4 Years
Current Role
Healthtech Community leader
Job Level
Junior
Location
Herzliya, Tel Aviv District, Israel
Personality Overview

How Sheila shows up

Communication Style
Decision Approach
Work Preference

Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.

Login to view personality overview.
Priorities

Topics Sheila cares about

Parkinson's Disease
Her career has been dedicated to this area, from leading the market launch of the drug AZILECT to her current role as Chief Parkinson’s Program Officer at Remepy.
Drug Development
Has extensive experience taking new drugs from initial clinical trials all the way to market launch, with expertise in clinical and regulatory strategy.
+5 more topics Login to view topics
Career

Work history

9-2024
Healthtech Community leader
Next October
4-2024
Chief Parkinson’s Program Officer
Remepy
8-2020
Senior Medical Advisor
SOREN Medical Consulting
11-2023 - 5-2024
Co-founder & CEO @ Anabasis
Anabasis LTD
1-2021 - 4-2023
Chief Executive Officer
Pharma Two B
In the press

Media appearances

No media yetWe could not find public media appearances for this person.
Education
1980 - 1988
Doctor of Medicine (MD)
School of Medicine, Tel Aviv University, Israel
2008 - 2009
MBA
Reichman University
Social presence
in
Behavioral profile

DISC profile (public)

DISC behavioral profile

Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.

Login to view DISC.

More profiles

Discover additional public profiles from our index.

Unlock the full playbookSee exactly how to sell to Sheila. Free, 10 seconds.